Which Glp-1 Is Best? Comparison Guide

If you are looking for a straight answer on which GLP-1 medication is best, here it is: There is no single “best” GLP-1 for everyone. The right choice depends on your primary goal — weight loss, blood sugar control, or both — and how your body handles the side effects. Semaglutide (Ozempic, Wegovy) has the strongest evidence for weight loss, while tirzepatide (Mounjaro, Zepbound) shows slightly higher average weight reduction in head-to-head trials. For diabetes management alone, liraglutide (Victoza) and dulaglutide (Trulicity) are well-established options with long safety records. This guide breaks down what the research actually shows so you can have an informed conversation with your doctor.

How Do GLP-1 Medications Work?

GLP-1 receptor agonists mimic a natural hormone called glucagon-like peptide-1. This hormone is released in your gut after you eat. It tells your pancreas to release insulin, which lowers blood sugar. It also slows down how fast food leaves your stomach. That is why people feel fuller longer on these drugs.

These medications also affect areas of the brain that control appetite. Research published in Nature Metabolism has shown that GLP-1 drugs reduce food cravings by acting on receptors in the hypothalamus. This is not a side effect — it is a designed part of how they work. Some newer GLP-1 drugs also target a second hormone receptor called GIP, which may add to the effect.

The original GLP-1 drugs were developed for type 2 diabetes. But as patients lost weight on them, researchers started studying them specifically for obesity. The FDA has now approved several GLP-1 drugs for weight management in people with a BMI of 30 or higher, or 27 with a weight-related condition.

Which GLP-1 Is Best for Weight Loss?

If weight loss is your main goal, tirzepatide (sold as Zepbound for weight loss and Mounjaro for diabetes) has the strongest data. In a 72-week clinical trial published in The New England Journal of Medicine, patients taking tirzepatide lost an average of 22.5% of their body weight at the highest dose. That is the largest average weight loss ever seen in a GLP-1 trial.

Semaglutide (Wegovy for weight loss, Ozempic for diabetes) is close behind. In the STEP 1 trial, patients lost an average of 14.9% of their body weight over 68 weeks. That is still a significant amount. Many people lose more than that in real-world use because the trials had strict protocols.

Liraglutide (Saxenda for weight loss, Victoza for diabetes) is less effective for weight loss. Clinical trials show average weight loss of about 4-6% of body weight. This drug requires daily injections rather than weekly, which some people find less convenient. It is generally considered a second-line option for weight loss now.

The table below shows a direct comparison of the main GLP-1 drugs approved for weight loss in the United States.

None of these numbers guarantee your personal result. Individual weight loss varies widely based on dose, diet, activity level, and genetics.

Which GLP-1 Is Best for Blood Sugar Control?

For type 2 diabetes, tirzepatide also leads in blood sugar reduction. In the SURPASS-2 trial, tirzepatide lowered A1C by 2.0-2.3 percentage points depending on dose. Semaglutide lowered A1C by 1.9 percentage points in the same head-to-head study. Both are excellent options.

Dulaglutide (Trulicity) has been on the market longer and has strong cardiovascular safety data. The REWIND trial showed that dulaglutide reduced major cardiovascular events by 12% in people with type 2 diabetes. This matters if you have heart disease or high risk for it.

Liraglutide also has cardiovascular benefits. The LEADER trial found a 13% reduction in cardiovascular death, heart attack, or stroke. The American Diabetes Association now recommends GLP-1 drugs as a first-line option for people with type 2 diabetes who have or are at high risk for heart disease.

For diabetes specifically, the choice often comes down to insurance coverage and side effect tolerance. All the major GLP-1 drugs lower blood sugar effectively. The differences between them are small for most patients.

What Are the Side Effects of GLP-1 Medications?

Side effects are common with all GLP-1 drugs. The most frequent ones are nausea, vomiting, diarrhea, constipation, and stomach pain. These usually happen when you first start the medication or when you increase the dose. Most people find the nausea improves over time, especially if they start at a low dose and go up slowly.

Nausea affects about 20-30% of people taking semaglutide and tirzepatide in clinical trials. Vomiting affects roughly 10-15%. Liraglutide has similar rates. The side effects tend to be dose-dependent — higher doses cause more stomach issues.

There are more serious but rare side effects. Pancreatitis (inflammation of the pancreas) has been reported. Gallbladder disease, including gallstones, is more common in people who lose weight rapidly on these drugs. The FDA requires a warning about thyroid C-cell tumors, which were seen in animal studies but have not been confirmed in humans.

A newer concern is gastroparesis — severe stomach paralysis where food moves too slowly through the digestive system. Case reports have emerged, but large studies have not confirmed how common this is. The FDA continues to monitor reports of this condition.

What Does Research on Which GLP-1 Is Best Actually Show?

The most direct comparison we have is the SURMOUNT-5 trial, which compared tirzepatide and semaglutide head-to-head for weight loss. Tirzepatide showed about 5% more weight loss on average. That sounds like a small difference, but at the highest doses it translates to roughly 10-15 more pounds lost over a year.

However, the dropout rates in these trials matter. In the SURMOUNT-5 trial, about 15% of participants stopped due to side effects. In real-world use, the numbers are higher. One study from the Cleveland Clinic found that nearly 40% of patients stopped taking GLP-1 drugs within a year. The most common reasons were side effects, cost, and not seeing enough results.

Research also shows that when people stop taking these drugs, most of the weight comes back. A study in Diabetes, Obesity and Metabolism found that one year after stopping semaglutide, participants regained two-thirds of the weight they had lost. This is not a failure of the drug — it means obesity is a chronic condition that requires ongoing treatment for many people.

Long-term data beyond two years is still limited. The SELECT trial is following patients on semaglutide for up to five years to look at cardiovascular outcomes. Early results showed a 20% reduction in heart attacks, strokes, and cardiovascular death. That is a significant finding that goes beyond weight loss alone.

How to Choose Between GLP-1 Medications

Your choice starts with your primary goal. If you want maximum weight loss and can tolerate side effects, tirzepatide has the strongest evidence. If you have type 2 diabetes with heart disease risk, dulaglutide or liraglutide have the longest cardiovascular safety data. If you want a middle ground with strong evidence for both weight and blood sugar, semaglutide is a solid option.

Cost and insurance coverage often make the decision for you. These drugs cost $900 to $1,300 per month without insurance. Many insurance plans require step therapy — you have to try an older, cheaper GLP-1 first before they cover the newer ones. Medicare Part D covers some GLP-1 drugs for diabetes but not for weight loss alone.

Dosing schedule matters too. Tirzepatide and semaglutide are weekly injections. Liraglutide is daily. Some people prefer daily because the side effects are less intense. Others prefer weekly for convenience. Your doctor can help you decide based on your lifestyle.

Here is a quick checklist of things to discuss with your doctor:

• Your BMI and whether you meet FDA criteria for weight loss drugs
• Whether you have type 2 diabetes or prediabetes
• Your history of pancreatitis, gallbladder disease, or thyroid cancer
• What your insurance covers and what your out-of-pocket cost would be
• Whether you are willing to stay on the medication long-term

Do not chase the newest drug just because it has the highest average weight loss. The best GLP-1 is the one you can actually take consistently, tolerate well, and afford.